期刊文献+

鲍曼不动杆菌的临床感染趋势与药敏试验 被引量:2

下载PDF
导出
摘要 目的阐述鲍曼不动杆菌临床感染的趋势及其耐药特点,协助临床医生合理用药。方法对送检的临床标本进行常规细菌培养,以ATB微生物分析仪进行鉴定,选择K-B纸片扩散法作药敏试验,用WHONET 5.4和SPSS 14.0软件对分离的鲍曼不动杆菌进行统计分析。结果鲍曼不动杆菌分离率为12.74%,最常见于呼吸道标本(88.4%),神经外科和重症ICU病区分离的鲍曼不动杆菌分别占41.5%、24.4%;鲍曼不动杆菌对亚胺培南、美洛培南、头孢哌酮/舒巴坦的耐药率分别为:8.5%、18.4%、28.2%,对哌拉西林、左氧氟沙星、头孢他啶、阿米卡星、头孢吡肟的耐药率均高于80%,分别为:87.5%、85.5%、82.4%、81.8%、81.6%。此外,检测到3株(1.83%)泛耐药(PDR)鲍曼不动杆菌。结论鲍曼不动杆菌分离率高,是当前医院感染的重要条件致病菌,其耐药现象严重,应引起临床的高度重视。
出处 《右江医学》 2009年第5期558-560,共3页 Chinese Youjiang Medical Journal
  • 相关文献

参考文献8

  • 1Chang P Y,Hsueh P R,Wu P S,et al. Multidrug-- resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan[J]. J Microbiol Immunol Infect, 2007,40 (5) 406--410.
  • 2PatwardhanRB, DhakephalkarPK, NiphadkarKB, etal. Astudy on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids [J]. Indian J Med Res, 2008,128(2): 178-- 187.
  • 3Rao R S,Karthika R U,Singh S P,et al. Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Aeinetobacter baumannii[J]. Indian J Med Microbiol,2008,26(4) :333--337.
  • 4Fontana C, Favaro M, Minelli S, et al. Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates[J]. BMC Infect Dis, 2008,8: 79.
  • 5Montefour K, Frieden J, Hurst S, et al. Acinetobacter baumannii: an emerging multidrug--resistant pathogen in critical care[J].Crit Care Nurse,2008,28(1):15- 2526.
  • 6宗志勇,雷秉钧,吕晓菊,高燕渝,俞汝佳.鲍曼不动杆菌耐药性和金属β内酰胺酶的检测[J].中华检验医学杂志,2005,28(10):999-1001. 被引量:23
  • 7Montefour K, Frieden J, Hurst S, et al. Acinetobacter baumannii : an emerging multidrug--resistant pathogen in critical care [J]. Crit Care Nurse,2008,28(1):15- 25.
  • 8王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237

二级参考文献26

  • 1王辉,孙宏莉,廖康,陈冬梅,王清涛,王飞燕,陈民钧,朱元珏.北京和广州地区四家医院不动杆菌碳青霉烯酶基因型研究[J].中华检验医学杂志,2005,28(6):636-641. 被引量:121
  • 2李杰 李霞.鲍曼不动杆菌鉴定及临床分布特征.中华医学检验杂志,1998,21(2):109-109.
  • 3Zong ZY, LU XJ, Gao YY. Metallo-β-lactamases of non-fermenting Gram-negative bacteria. Rev Med Microbiol, 2003, 14 : 79-94.
  • 4Livermore DM. The impact of carbapenemases on antimicrobial development and therapy. Curr Opin Investig Drugs, 2002, 3:218-224.
  • 5Senda K, Arakawa Y, Nakashima K, et al. Multifocal outbreaks of metallo-beta-lactamase producing Psendomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicreb Agents Chemother, 1996, 40 : 349-353.
  • 6Hirakata Y, Izumikawa K, Yamaguchi T. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative reds carrying the metallo-beta-lactamase gene blaIMP. Antimicreb Agents Chemother, 1998, 42: 2006-2011.
  • 7Migliavacca R, Docquier JD, Mugnaioli C, et al. Simple microdilution test for detection of metallo-beta-lactamase production in Pseudomonas aeruginosa. J Clin Microbiol, 2002, 40: 4388-4390.
  • 8Levin AS. Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem. Clin Microbiol Infect, 2002, 8 : 144-153.
  • 9Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicreb Agents, 2003, 21:58-62.
  • 10Manikal VM,Landman D,Saurina G,et al.Endemic carbapenemresistant Acinetobacter species in Brooklyn,New York:citywide prevalence,interinstitutional spread,and relation to antibiotic usage.Clin Infect Dis,2000,31:101-106.

共引文献254

同被引文献12

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部